Savannah Chrisley's weight loss website receives FDA warning for misleading claims

dailymail.co.uk

Savannah Chrisley received a federal warning from the FDA for misleading claims on her weight loss website. The FDA cited her website's use of phrases like "FDA-approved meds" for compounded semaglutide and tirzepatide, stating these products are not FDA-approved and implying unproven safety and effectiveness. Chrisley clarified the issue was about website wording, not patient safety, and has since updated the site with disclaimers and corrected phrasing.


With a significance score of 0.7, this news ranks in the top 96% of today's 32162 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Savannah Chrisley's weight loss website receives FDA warning for misleading claims | News Minimalist